BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 18930421)

  • 21. [The "Seville" Consensus Document on Alternatives to Allogenic Blood Transfusion. Sociedades españolas de Anestesiología (SEDAR), Medicina Intensiva (SEMICYUC), Hematología y Hemoterapia (AEHH), Transfusión sanguínea (SETS) Trombosis y Hemostasia (SETH)].
    Alberca I; Asuero MS; Bóveda JL; Carpio N; Contreras E; Fernández-Mondéjar E; Forteza A; García-Erce JA; García de Lorenzo A; Gomar C; Gómez A; Llau JV; López-Fernández MF; Moral V; Muñoz M; Páramo JA; Torrabadella P; Quintana M; Sánchez C
    Med Clin (Barc); 2006 Jul; 127 Suppl 1():3-20. PubMed ID: 17020674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Elwatidy S; Jamjoom Z; Elgamal E; Zakaria A; Turkistani A; El-Dawlatly A
    Spine (Phila Pa 1976); 2008 Nov; 33(24):2577-80. PubMed ID: 19011538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfusion medicine : support of patients undergoing cardiac surgery.
    Goodnough LT; Despotis GJ
    Am J Cardiovasc Drugs; 2001; 1(5):337-51. PubMed ID: 14728016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies for minimizing the use of allogeneic blood during orthopedic surgery.
    Rosenblatt MA
    Mt Sinai J Med; 2002; 69(1-2):83-7. PubMed ID: 11832977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfusion-free surgery is a treatment plan for all patients.
    Trovarelli T; Kahn B; Vernon S
    AORN J; 1998 Nov; 68(5):773-8, 780-4. PubMed ID: 9829129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing perioperative blood loss and allogeneic blood transfusion in patients undergoing major spine surgery.
    Tse EY; Cheung WY; Ng KF; Luk KD
    J Bone Joint Surg Am; 2011 Jul; 93(13):1268-77. PubMed ID: 21776581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood conservation in neurosurgery: erythropoietin and autologous donation.
    McGirr A; Pavenski K; Sharma B; Cusimano MD
    Can J Neurol Sci; 2014 Sep; 41(5):583-9. PubMed ID: 25373808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Single Preoperative Dose of Tranexamic Acid on Blood Loss and Transfusion in Hip Arthroplasty.
    Jaszczyk M; Kozerawski D; Kołodziej Ł; Kazimierczak A; Sarnecki P; Sieczka Ł
    Ortop Traumatol Rehabil; 2015; 17(3):265-73. PubMed ID: 26248628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery.
    Vonk AB; Meesters MI; Schats J; Romijn JW; Jansen EK; Boer C
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):135-9. PubMed ID: 21075830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methods of reducing allogeneic blood demand in orthopedic surgery.
    Dragan S; Kulej M; Krawczyk A; Wall A; Płocieniak K; Urbański W
    Ortop Traumatol Rehabil; 2012; 14(3):199-214. PubMed ID: 22764333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies to reduce blood loss in lower extremity total joint arthroplasty.
    Ulrich SD; Kyle B; Johnson AJ; Zywiel MG; Mont MA
    Surg Technol Int; 2010 Oct; 20():341-7. PubMed ID: 21082584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current status of pharmacologic therapies in patient blood management.
    Goodnough LT; Shander A
    Anesth Analg; 2013 Jan; 116(1):15-34. PubMed ID: 23223098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacological reduction of bleeding during hip endoprosthetic replacement].
    de Jonge T
    Orv Hetil; 2012 Oct; 153(41):1607-12. PubMed ID: 23045310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preoperative strategy for homologous blood salvage and peri-operative erythropoietin].
    Rosencher N; Woimant G; Ozier Y; Conseiller C
    Transfus Clin Biol; 1999 Dec; 6(6):370-9. PubMed ID: 10666795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
    Levi M; Cromheecke ME; de Jonge E; Prins MH; de Mol BJ; Briët E; Büller HR
    Lancet; 1999 Dec; 354(9194):1940-7. PubMed ID: 10622296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood conservation in revision total hip arthroplasty.
    Dennis DA
    Semin Arthroplasty; 1992 Oct; 3(4):246-56. PubMed ID: 10147934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline.
    ; Ferraris VA; Ferraris SP; Saha SP; Hessel EA; Haan CK; Royston BD; Bridges CR; Higgins RS; Despotis G; Brown JR; ; Spiess BD; Shore-Lesserson L; Stafford-Smith M; Mazer CD; Bennett-Guerrero E; Hill SE; Body S
    Ann Thorac Surg; 2007 May; 83(5 Suppl):S27-86. PubMed ID: 17462454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perioperative coagulation management and blood conservation in cardiac surgery: a Canadian Survey.
    Taneja R; Fernandes P; Marwaha G; Cheng D; Bainbridge D
    J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):662-9. PubMed ID: 18922420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Autologous blood pre-donation and perioperative use of erythropoietin].
    Michaeli B; Ravussin P; Chassot PG
    Rev Med Suisse; 2006 Nov; 2(88):2662-4, 2666-7. PubMed ID: 17265804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing transfusion in vascular surgery: is bloodless surgery an option?
    Shander A
    Vascular; 2008; 16 Suppl 1():S37-47. PubMed ID: 18544304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.